Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
about
Attention-Deficit Hyperactivity Disorder in GirlsThe adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorderPrescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysisPsychostimulants and cognition: a continuum of behavioral and cognitive activationMethylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbensAddiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsCognitive enhancers for the treatment of ADHDADHD in Children Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity DisorderMethylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of harmful effects in non-randomised studiesAtomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescentsThe 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHDAttention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity)Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implicationsPotential adverse effects of amphetamine treatment on brain and behavior: a reviewNeuropharmacological mechanisms underlying the neuroprotective effects of methylphenidateAssessing the molecular genetics of attention networks.Neuropsychological effects of chronic low-dose exposure to polychlorinated biphenyls (PCBs): a cross-sectional study.5p deletions: Current knowledge and future directions.Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with CarboplatinChanges in behavior as side effects in methylphenidate treatment: review of the literatureThe substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophreniaSources of openness/intellect: cognitive and neuropsychological correlates of the fifth factor of personalityThe impact of genetic research on our understanding of normal cognitive ageing: 1995 to 2009Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedilThe other face of depression, reduced positive affect: the role of catecholamines in causation and cureLong-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system developmentEnvironmental enrichment preceding early adulthood methylphenidate treatment leads to long term increase of corticosterone and testosterone in the ratAgeing increases reliance on sensorimotor prediction through structural and functional differences in frontostriatal circuitsEffects of chronic and acute stimulants on brain functional connectivity hubsDecision making: effects of methylphenidate on temporal discounting in nonhuman primates.Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction.Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addictionCognitive effects of nicotine: genetic moderators.Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task.Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling.Reinforcement, dopamine and rodent models in drug development for ADHDNeuropharmacology and receptor studies in the elderly.Methylphenidate and desipramine combined treatment improves PTSD symptomatology in a rat modelA review of the biological bases of ADHD: what have we learned from imaging studies?Executive dyscontrol in normal aging: normative data, factor structure, and clinical correlates.
P2860
Q22241431-92CB75EA-C7E8-4520-ACE2-CF305533FD73Q22241830-25D225A2-E000-4DF1-BD22-D3A72ADD25E2Q22241909-1C7CF4D4-5DA5-4E20-AB05-CD9A57383C83Q22242285-3A5A5151-C84C-44B6-B40F-30466A943613Q22248089-B590B18B-A9FC-4625-BE1F-4D894A08557BQ22251215-CAD0FCA7-4115-4BCA-AF81-07266D88E2FCQ22251235-8C92D3F5-DF5C-4DA5-AE6C-5C18B8BE9367Q22305481-C2667EDB-972C-4844-A2B3-9920C89AD2F1Q24186221-AB702B33-0F71-417B-920D-E9111D57196FQ24200716-D545710C-E25D-47BB-9C07-B16AF09CB0CAQ24288955-4666D932-69DD-4583-9784-76C393E68CC2Q24547458-2D351821-8B19-4FC1-966E-1C19163AB50EQ24645440-F0526D2F-2B10-4BA6-88B2-7EC52ECD25D5Q24657966-C8EC9D03-2970-4760-B88F-D85A84AAAF92Q24658233-F77D375F-7C5E-432F-B888-6C2216D9990DQ24792049-AD18EBFB-568A-4D9B-8225-34CB04D51D41Q24813880-298E5C07-8A7B-4CAC-8FA9-781F04E8066EQ26800129-D228023A-BC23-4557-AC3B-84BC29B34C55Q27300384-A9D3E859-7B32-4640-9F8D-9B9A32E32BFEQ28078623-260A6C36-7A72-48F0-9125-0A7B34A82DBBQ28210979-4FCDB701-064D-49C7-8D9C-B12F9854F4EFQ28256718-2A99D6CD-FDC6-4D3B-AFAB-895E54EA9386Q28259199-E798F54B-D7EF-40BB-A9A5-F9E9FD6B58EFQ28261289-D9BF55E3-861E-410A-8B14-25D53D6A030EQ28269179-EE6A055F-B9FD-41FA-858F-6AD889BEABC8Q28389867-09A3E62F-DD8F-4F1F-9E7B-2CA9AB6DD30BQ28479049-890D66E8-9B5F-4635-A7F4-105B7CEFFC0CQ28597588-21B71D48-3D4D-4106-B90C-A5164DE5D521Q30368455-2DE17D84-3CB6-4825-8A20-D1424324CABDQ30380367-7AB31CF0-CECD-4BB7-A0D1-978A3FE3D52CQ30416778-78B0ED42-0DB3-4D6E-854D-59092D49FF0AQ30417580-50B3EA4C-7E63-4118-9FBE-9A3292E78C90Q30474904-76C8816D-8049-4897-8A23-65E2D15689C8Q30476288-EB752378-91D3-44A0-8505-AD15F9319F40Q30481214-27E10776-A06F-4BFB-9A66-49A2724761FEQ30524906-D83647BC-EBB9-4ED5-9011-61815BC2F7DCQ30585270-6DCC8036-A1AB-41A2-BF71-E84BBBD547CDQ30594365-126CC219-06E0-4E50-A888-CC59E0F361A1Q30822545-798BDCCC-BADA-430B-8824-8FF73628D37AQ30882429-C9709964-C2E1-499D-8114-DC4BF2C091B3
P2860
Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@ast
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@en
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@nl
type
label
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@ast
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@en
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@nl
prefLabel
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@ast
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@en
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@nl
P2093
P356
P1476
Dopamine transporter occupanci ...... doses of oral methylphenidate.
@en
P2093
Hitzemann R
P304
P356
10.1176/AJP.155.10.1325
P407
P577
1998-10-01T00:00:00Z